Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study.

Details

Ressource 1Request a copy Sous embargo indéterminé.
State: Public
Version: author
Serval ID
serval:BIB_3980C0F4274B
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study.
Journal
European Journal of Cardiovascular Prevention and Rehabilitation
Author(s)
Danon-Hersch N., Marques-Vidal P., Bovet P., Chiolero A., Paccaud F., Pécoud A., Hayoz D., Mooser V., Waeber G., Vollenweider P.
ISSN
1741-8275
ISSN-L
1741-8267
Publication state
Published
Issued date
2009
Peer-reviewed
Oui
Volume
16
Number
1
Pages
66-72
Language
english
Abstract
BACKGROUND: This study is aimed to assess the prevalence of awareness, treatment and control of high blood pressure (HBP) and associated factors in a Swiss city. DESIGN: Population-based cross-sectional study of 6182 participants (52.5% women) aged 35-75 years living in Lausanne, Switzerland. METHODS: HBP was defined as blood pressure >/=140/90 mmHg or current antihypertensive medication. RESULTS: The overall prevalence of HBP was 36% (95% confidence interval: 35-38%). Among participants with HBP, 63% were aware of it. Among participants aware of HBP, 78% were treated, and among those treated, 48% were controlled (BP <140/90 mmHg). In multivariate analysis, HBP prevalence was associated with older age, male sex, low educational level, high alcohol intake, awareness of diabetes or dyslipidaemia, obesity and parental history of myocardial infarction. HBP awareness was associated with older age, female sex, awareness of diabetes or dyslipidaemia, obesity and parental history of myocardial infarction. HBP control was associated with younger age, higher educational level and no alcohol intake. Alone or in combination, sartans were the most often prescribed antihypertensive medication category (41%), followed by diuretics, beta-blockers, angiotensin converting enzyme inhibitors and calcium channel blockers. Only 31% of participants treated for HBP were taking >/=2 antihypertensive medications. CONCLUSION: Although more than half of all participants with HBP were aware and more than three-quarters of them received a pharmacological treatment, less than half of those treated were adequately controlled.
Keywords
Adrenergic beta-Antagonists/therapeutic use, Adult, Age Factors, Alcohol Drinking/epidemiology, Angiotensin II Type 1 Receptor Blockers/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Calcium Channel Blockers/therapeutic use, Cross-Sectional Studies, Diabetes Mellitus/epidemiology, Diuretics/therapeutic use, Drug Utilization, Dyslipidemias/epidemiology, Educational Status, Female, Health Knowledge, Attitudes, Practice, Humans, Hypertension/drug therapy, Hypertension/epidemiology, Male, Middle Aged, Multivariate Analysis, Myocardial Infarction/epidemiology, Obesity/epidemiology, Prevalence, Sampling Studies, Sex Factors, Switzerland/epidemiology, Urban Population , Colaus Study
Pubmed
Web of science
Create date
02/03/2009 19:42
Last modification date
20/08/2019 14:29
Usage data